| Dapagliflozin |
Anti-Diabetic (SGLT2) |
In-house / USP |
| Empagliflozin |
Anti-Diabetic (SGLT2) |
In-house |
| Sotagliflozin |
Anti-Diabetic (SGLT2) |
1018899-04-1 |
| Linagliptin |
Anti-Diabetic (DPP-4) |
US DMF |
| Sitagliptin HCl |
Anti-Diabetic (DPP-4) |
US DMF |
| Sitagliptin Phosphate Monohydrate |
Anti-Diabetic (DPP-4) |
IP/USP/EP |
| Vildagliptin |
Anti-Diabetic (DPP-4) |
TFDA, US DMF |
| Imeglimin HCl |
Anti-Diabetic |
775351-61-6 |
| Nateglinide (Form H) |
Anti-Diabetic |
EU CEP, US DMF |
| Pregabalin |
Diabetic Neuropathy / CNS |
IP/BP/USP |
| Mirogabalin / Mirogabalin Besylate |
Diabetic Neuropathy |
1138245-21-2 |
